Vanguard Global Advisers’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$598K Sell
73,261
-635
-0.9% -$9.48K ﹤0.01% 2020
2026
Q2
$1.76M Sell
73,896
-98
-0.1% -$1.88K ﹤0.01% 1355
2026
Q1
$1.3M Buy
+73,994
New +$1.49M ﹤0.01% 1474

Other funds holding ALHC

Vanguard Global Advisers's ALHC Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Alignment Healthcare (ALHC) stake by 0.86% in Q3 2026, selling an estimated $9.48K and leaving 73,261 shares worth $598K. The position accounts for ﹤0.01% of the portfolio, ranked #2020.

Vanguard Global Advisers first reported a position in ALHC in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.76M in Q2 2026. 323 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • Vanguard Global Advisers held 73,261 shares of Alignment Healthcare worth $598K as of Q3 2026.
  • Vanguard Global Advisers sold 635 Alignment Healthcare shares in Q3 2026, an estimated $9.48K.
  • Alignment Healthcare made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2020 holding.
  • Vanguard Global Advisers first reported a position in Alignment Healthcare in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Alignment Healthcare position peaked at $1.76M in Q2 2026.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.